C-reactive protein; A potential marker of second cancer and cardiovascular disease in testicular cancer survivors?

European Journal of Cancer

Volumn 46, Issue 18, 2010, Pages 3425-3433

  Wethal, T ^a   Haugnes, H S ^b   Kjekshus, J ^a   Smstuen, M C ^c,d   Ueland, T ^a   Aukrust, P ^a,d   Foss, S D ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Cancer Registry of Norway ^*  (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

C reactive protein; Cardiovascular disease; Second cancer; Testicular cancer survivors

Indexed keywords

BIOLOGICAL MARKER; BLEOMYCIN; C REACTIVE PROTEIN; CISPLATIN; ETOPOSIDE; VINBLASTINE;

ADULT; ARTICLE; BLADDER CANCER; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; FOLLOW UP; GERM CELL TUMOR; HEALTH SURVEY; HEART DEATH; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NON GERM CELL CANCER; NORWAY; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; SECOND CANCER; SENSITIVITY AND SPECIFICITY; SKIN CANCER; STROKE; TESTIS CANCER;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SURVIVORS; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78649630857     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.08.004     Document Type: Article

References (30)

1. J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
2. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
3. L. Lind Circulating markers of inflammation and atherosclerosis Atherosclerosis 169 2003 203 214
4. W.W. Lin, and M. Karin A cytokine-mediated link between innate immunity, inflammation, and cancer J Clin Invest 117 2007 1175 1183
5. K.H. Allin, S.E. Bojesen, and B.G. Nordestgaard Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer J Clin Oncol 27 2009 2217 2224
6. C. Siemes, L.E. Visser, and J.W. Coebergh C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam study J Clin Oncol 24 2006 5216 5222
7. K.K. Tsilidis, C. Branchini, and E. Guallar C-reactive protein and colorectal cancer risk: a systematic review of prospective studies Int J Cancer 123 2008 1133 1140
8. N. Rifai, J.E. Buring, I.M. Lee, J.E. Manson, and P.M. Ridker Is C-reactive protein specific for vascular disease in women? Ann Intern Med 136 2002 529 533
9. S.M. Zhang, J. Lin, and N.R. Cook C-reactive protein and risk of breast cancer J Natl Cancer Inst 99 2007 890 894
10. S.D. Fossa, N. Aass, S. Harvei, and S. Tretli Increased mortality rates in young and middle-aged patients with malignant germ cell tumours Br J Cancer 90 2004 607 612
11. S.D. Fossa, E. Gilbert, and G.M. Dores Noncancer causes of death in survivors of testicular cancer J Natl Cancer Inst 99 2007 533 544
12. R.A. Huddart, A. Norman, and M. Shahidi Cardiovascular disease as a long-term complication of treatment for testicular cancer J Clin Oncol 21 2003 1513 1523
13. A.W. van den Belt-Dusebout, J. Nuver, and W.R. de Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer J Clin Oncol 24 2006 467 475
14. J. Nuver, A.J. Smit, and D.T. Sleijfer Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer Eur J Cancer 40 2004 701 706
15. T. Wethal, J. Kjekshus, and J. Roislien Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer J Cancer Surviv 1 2007 8 16
16. C. Nord, T. Bjoro, and D. Ellingsen Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer Eur Urol 44 2003 322 328
17. D. Robinson, H. Moller, and A. Horwich Mortality and incidence of second cancers following treatment for testicular cancer Br J Cancer 96 2007 529 533
18. L.B. Travis, S.D. Fossa, and S.J. Schonfeld Second cancers among 40,576 testicular cancer patients: focus on long-term survivors J Natl Cancer Inst 97 2005 1354 1365
19. J.A. Gietema, M.T. Meinardi, and J. Messerschmidt Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer Lancet 355 2000 1075 1076
20. A. Gerl, and R. Schierl Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer Acta Oncol 39 2000 519 522
21. D.C. McMillan, K. Canna, and C.S. McArdle Systemic inflammatory response predicts survival following curative resection of colorectal cancer Br J Surg 90 2003 215 219
22. T.M. Beer, A.S. Lalani, and S. Lee C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial Cancer 112 2008 2377 2383
23. M. Tatokoro, K. Saito, and Y. Iimura Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy J Urol 180 2008 515 519
24. J. Nuver, A.J. Smit, and B.H. Wolffenbuttel The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer J Clin Oncol 23 2005 3718 3725
25. H. Sagstuen, N. Aass, and S.D. Fossa Blood pressure and body mass index in long-term survivors of testicular cancer J Clin Oncol 23 2005 4980 4990
26. D.J. Vaughn, S.C. Palmer, J.R. Carver, L.A. Jacobs, and E.R. Mohler Cardiovascular risk in long-term survivors of testicular cancer Cancer 112 2008 1949 1953
27. Dorresteijn LD, Kappelle AC, Scholz NM et al. Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer 2005;41:1026-30.28].
28. S.R. Basavaraju, and C.E. Easterly Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications Med Phys 29 2002 2391 2403
29. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352:20-8.
30. O. Melander, C. Newton-Cheh, and P. Almgren Novel and conventional biomarkers for prediction of incident cardiovascular events in the community JAMA 302 2009 49 57